Neurodevelopment, GABA system dysfunction, and schizophrenia

Neuropsychopharmacology

Volumn 40, Issue 1, 2015, Pages 190-206

  Schmidt, Martin J ^a   Mirnics, Karoly ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR;

ANIMAL; BRAIN; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SCHIZOPHRENIA;

ANIMALS; BRAIN; GAMMA-AMINOBUTYRIC ACID; HUMANS; RECEPTORS, GABA; RISK FACTORS; SCHIZOPHRENIA;

EID: 84900721647     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.95     Document Type: Review

References (344)

1. Abazyan B, Nomura J, Kannan G, Ishizuka K, Tamashiro KL, Nucifora F et al (2010). Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68: 1172-1181.
2. Aberg KA, Liu Y, Bukszar J, McClay JL, Khachane AN, Andreassen OA et al (2013). A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry 70: 573-581.
3. Abraham H, Meyer G (2003). Reelin-expressing neurons in the postnatal and adult human hippocampal formation. Hippocampus 13: 715-727.
4. Adam D (2013). Mental health: on the spectrum. Nature 496: 416-418.
5. Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Hagman JO, Sandman CA et al (1993a). Altered distribution of nicotinamide-adenine dinucleotide phosphatediaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50: 169-177.
6. Akbarian S, Huang HS (2006). Molecular and cellular mechanisms of altered GAD1/ GAD67 expression in schizophrenia and related disorders. Brain Res Rev 52: 293-304.
7. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr et al (1995). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52: 258-266.
8. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE Jr, Jones EG (1996). Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 53: 425-436.
9. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE Jr, Jones EG (1993b). Distorted distribution of nicotinamide-adenine dinucleotide phosphate- diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50: 178-187.
10. Alcantara S, Pozas E, Ibanez CF, Soriano E (2006). BDNF-modulated spatial organization of Cajal-Retzius and GABAergic neurons in the marginal zone plays a role in the development of cortical organization. Cereb Cortex 16: 487-499.
11. Anderson SA, Marin O, Horn C, Jennings K, Rubenstein JL (2001). Distinct cortical migrations from the medial and lateral ganglionic eminences. Development 128: 353-363.
12. Anderson SA, Volk DW, Lewis DA (1996). Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res 19: 111-119.
13. Arion D, Horvath S, Lewis DA, Mirnics K (2010). Infragranular gene expression disturbances in the prefrontal cortex in schizophrenia: signature of altered neural development? Neurobiol Dis 37: 738-746.
14. Arion D, Lewis DA (2011). Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia. Arch Gen Psychiatry 68: 21-31.
15. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K (2007). Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 62: 711-721.
16. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR (1991). Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48: 625-632.
17. Aronne MP, Guadagnoli T, Fontanet P, Evrard SG, Brusco A (2011). Effects of prenatal ethanol exposure on rat brain radial glia and neuroblast migration. Exp Neurol 229: 364-371.
18. Arseneault L, Cannon M, Witton J, Murray RM (2004). Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184: 110-117.
19. Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N et al (1997). Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94: 6496-6499.
20. Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-Piccione R, Burkhalter A et al (2008). Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci 9: 557-568.
21. Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim B, Krasnova IN et al (2011). Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry 16: 293-306.
22. Barakat A, Dean B, Scarr E, Evin G (2010). Decreased neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia. Schizophr Res 124: 200-207.
23. Barbin G, Pollard H, Gaiarsa JL, Ben-Ari Y (1993). Involvement of GABAA receptors in the outgrowth of cultured hippocampal neurons. Neurosci Lett 152: 150-154.
24. Bartolini G, Ciceri G, Marin O (2013). Integration of GABAergic interneurons into cortical cell assemblies: lessons from embryos and adults. Neuron 79: 849-864.
25. Beasley CL, Honavar M, Everall IP, Cotter D (2009). Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder. Schizophr Res 115: 156-162.
26. Behar TN, Dugich-Djordjevic MM, Li YX, Ma W, Somogyi R, Wen X et al (1997). Neurotrophins stimulate chemotaxis of embryonic cortical neurons. Eur J Neurosci 9: 2561-2570.
27. Behar TN, Schaffner AE, Scott CA, Greene CL, Barker JL (2000). GABA receptor antagonists modulate postmitotic cell migration in slice cultures of embryonic rat cortex. Cereb Cortex 10: 899-909.
28. Behar TN, Smith SV, Kennedy RT, McKenzie JM, Maric I, Barker JL (2001). GABA(B) receptors mediate motility signals for migrating embryonic cortical cells. Cereb Cortex 11: 744-753.
29. Ben-Ari Y (2002). Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci 3: 728-739.
30. Benes FM (1993). Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr Bull 19: 537-549.
31. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL (1991). Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48: 996-1001.
32. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP (1992). Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12: 924-929.
33. Berninger B, Marty S, Zafra F, da Penha Berzaghi M, Thoenen H, Lindholm D (1995). GABAergic stimulation switches from enhancing to repressing BDNF expression in rat hippocampal neurons during maturation in vitro. Development 121: 2327-2335.
34. Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P et al (1998). Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83: 867-875.
35. Bielle F, Griveau A, Narboux-Neme N, Vigneau S, Sigrist M, Arber S et al (2005). Multiple origins of Cajal-Retzius cells at the borders of the developing pallium. Nat Neurosci 8: 1002-1012.
36. Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U (2010). Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 35: 2462-2478.
37. Blue ME, Naidu S, Johnston MV (1999). Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 156: 345-352.
38. Boulle F, van den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J et al (2011). Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 17: 584-596.
39. Brandon NJ, Sawa A (2011). Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci 12: 707-722.
40. Brauns S, Gollub RL, Roffman JL, Yendiki A, Ho BC, Wassink TH et al (2011). DISC1 is associated with cortical thickness and neural efficiency. NeuroImage 57: 1591-1600.
41. Brown AS (2011). The environment and susceptibility to schizophrenia. Prog Neurobiol 93: 23-58.
42. Brown AS, Derkits EJ (2010). Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167: 261-280.
43. Brown JA, Horvath S, Garbett KA, Schmidt MJ, Everheart M, Gellert L et al (2013). The role of cannabinoid 1 receptor expressing interneurons in behavior. Neurobiol Dis 63C: 210-221.
44. Brune M, Schobel A, Karau R, Benali A, Faustmann PM, Juckel G et al (2010). Von Economo neuron density in the anterior cingulate cortex is reduced in early onset schizophrenia. Acta Neuropathol 119: 771-778.
45. Bystron I, Blakemore C, Rakic P (2008). Development of the human cerebral cortex: Boulder Committee revisited. Nat Rev Neurosci 9: 110-122.
46. Callicott JH, Feighery EL, Mattay VS, White MG, Chen Q, Baranger DA et al (2013). DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity. J Clin Invest 123: 2961-2964.
47. Canetta SE, Brown AS (2012). Prenatal infection, maternal immune activation, and risk for schizophrenia. Transl Neurosci 3: 320-327.
48. Cannon TD, van Erp TG, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T et al (2002). Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 59: 35-41.
49. Cantor-Graae E, Selten JP (2005). Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162: 12-24.
50. Cardno AG, Gottesman II (2000). Twin studies of schizophrenia: from bow-andarrow concordances to star wars Mx and functional genomics. Am J Med Genet 97: 12-17.
51. Cellerino A, Maffei L, Domenici L (1996). The distribution of brain-derived neurotrophic factor and its receptor trkB in parvalbumin-containing neurons of the rat visual cortex. Eur J Neurosci 8: 1190-1197.
52. Cellot G, Cherubini E (2013). Functional role of ambient GABA in refining neuronal circuits early in postnatal development. Front Neural Circuits 7: 136.
53. Chance SA, Walker M, Crow TJ (2005). Reduced density of calbindin-immunoreactive interneurons in the planum temporale in schizophrenia. Brain Res 1046: 32-37.
54. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J et al (2010). Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468: 263-269.
55. Chattopadhyaya B, Di Cristo G, Wu CZ, Knott G, Kuhlman S, Fu Y et al (2007). GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron 54: 889-903.
56. Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA et al (2013). Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry 18: 1308-1314.
57. Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS (2008). Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 100: 270-280.
58. Chrousos GP, Gold PW (1992). The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
59. Chun JJM, Shatz CJ (1989). Interstitial-cells of the adult neocortical white matter are the remnant of the early generated subplate neuron population. J Comp Neurol 282: 555-569.
60. Ciceri G, Dehorter N, Sols I, Huang ZJ, Maravall M, Marin O (2013). Lineagespecific laminar organization of cortical GABAergic interneurons. Nat Neurosci 16: 1199-1210.
61. Clay HB, Sillivan S, Konradi C (2010). Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29: 311-324.
62. Connor CM, Guo Y, Akbarian S (2009). Cingulate white matter neurons in schizophrenia and bipolar disorder. Biol Psychiatry 66: 486-493.
63. Corcoran C, Walker E, Huot R, Mittal V, Tessner K, Kestler L et al (2003). The stress cascade and schizophrenia: etiology and onset. Schizophr Bull 29: 671-692.
64. Costa E, Davis JM, Dong E, Grayson DR, Guidotti A, Tremolizzo L et al (2004). A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 16: 1-23.
65. Costa E, Grayson DR, Mitchell CP, Tremolizzo L, Veldic M, Guidotti A (2003). GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit Rev Neurobiol 15: 121-142.
66. Cross-Disorder Group of the Psychiatric Genomics C, Genetic Risk Outcome of Psychosis C (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381: 1371-1379.
67. Cullen TJ, Walker MA, Eastwood SL, Esiri MM, Harrison PJ, Crow TJ (2006). Anomalies of asymmetry of pyramidal cell density and structure in dorsolateral prefrontal cortex in schizophrenia. Br J Psychiatry 188: 26-31.
68. Curley AA, Arion D, Volk DW, Asafu-Adjei JK, Sampson AR, Fish KN et al (2011). Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry 168: 921-929.
69. Cuthbert BN, Insel TR (2013). Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11: 126.
70. Cuzon VC, Yeh PW, Yanagawa Y, Obata K, Yeh HH (2008). Ethanol consumption during early pregnancy alters the disposition of tangentially migrating GABAergic interneurons in the fetal cortex. J Neurosci 28: 1854-1864.
71. Dalman C, Allebeck P, Cullberg J, Grunewald C, Koster M (1999). Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch Gen Psychiatry 56: 234-240.
72. Danglot L, Triller A, Marty S (2006). The development of hippocampal interneurons in rodents. Hippocampus 16: 1032-1060.
73. Daviss SR, Lewis DA (1995). Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 59: 81-96.
74. de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG et al (2012). A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One 7: e39498.
75. DeFelipe J, Lopez-Cruz PL, Benavides-Piccione R, Bielza C, Larranaga P, Anderson S et al (2013). New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci 14: 202-216.
76. Del Pino I, Garcia-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martinez de Lagran M et al (2013). Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 79: 1152-1168.
77. Desbonnet L, O'Tuathaigh C, Clarke G, O'Leary C, Petit E, Clarke N et al (2012). Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene- environment interaction. Brain Behav Immun 26: 660-671.
78. Deslauriers J, Larouche A, Sarret P, Grignon S (2013). Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/ GABAergic markers. Progr Neuro-psychopharmacol Biol Psychiatry 45: 156-164.
79. Di Rosa E, Crow TJ, Walker MA, Black G, Chance SA (2009). Reduced neuron density, enlarged minicolumn spacing and altered ageing effects in fusiform cortex in schizophrenia. Psychiatry Res 166: 102-115.
80. Dorph-Petersen KA, Delevich KM, Marcsisin MJ, Zhang W, Sampson AR, Gundersen HJ et al (2009). Pyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophrenia. Brain Res 1285: 42-57.
81. Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA (2007). Primary visual cortex volume and total neuron number are reduced in schizophrenia. J Comp Neurol 501: 290-301.
82. Duan X, Chang JH, Ge S, Faulkner RL, Kim JY, Kitabatake Y et al (2007). Disruptedin- schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 130: 1146-1158.
83. Ducharme G, Lowe GC, Goutagny R, Williams S (2012). Early alterations in hippocampal circuitry and theta rhythm generation in a mouse model of prenatal infection: implications for schizophrenia. PLoS One 7: e29754.
84. Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH (2013). Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 147: 1-13.
85. Eastwood SL, Harrison PJ (2005). Interstitial white matter neuron density in the dorsolateral prefrontal cortex and parahippocampal gyrus in schizophrenia. Schizophr Res 79: 181-188.
86. Eastwood SL, Harrison PJ (2006). Cellular basis of reduced cortical reelin expression in schizophrenia. Am J Psychiatry 163: 540-542.
87. Edden RA, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH (2012). Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 69: 750-753.
88. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al (2003a). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
89. Egan MF, Weinberger DR, Lu B (2003b). Schizophrenia, III: brain-derived neurotropic factor and genetic risk. Am J Psychiatry 160: 1242.
90. Eggan SM, Melchitzky DS, Sesack SR, Fish KN, Lewis DA (2010). Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience 169: 1651-1661.
91. Eisenberg DP, Ianni AM, Wei SM, Kohn PD, Kolachana B, Apud J et al (2013). Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia. Mol Psychiatry 18: 713-720.
92. Falkai P, Schneider-Axmann T, Honer WG (2000). Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry 47: 937-943.
93. Fatemi SH, Earle JA, McMenomy T (2000). Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 5: 571.
94. Fatemi SH, Folsom TD, Rooney RJ, Thuras PD (2013). Expression of GABAA alpha2-, beta1- and epsilon-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry 3: e303.
95. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR (2002). Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52: 805-810.
96. Fatemi SH, Kroll JL, Stary JM (2001). Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. NeuroReport 12: 3209-3215.
97. Fatemi SH, Reutiman TJ, Folsom TD, Rooney RJ, Patel DH, Thuras PD (2010). mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism. J Autism Dev Disord 40: 743-750.
98. Fatemi SH, Stary JM, Earle JA, Araghi-Niknam M, Eagan E (2005). GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res 72: 109-122.
99. Fazzari P, Paternain AV, Valiente M, Pla R, Lujan R, Lloyd K et al (2010). Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 464: 1376-1380.
100. Fisahn A, Neddens J, Yan L, Buonanno A (2009). Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb Cortex 19: 612-618.
101. Fish KN, Sweet RA, Lewis DA (2011). Differential distribution of proteins regulating GABA synthesis and reuptake in axon boutons of subpopulations of cortical interneurons. Cerebral Cortex 21: 2450-2460.
102. Flames N, Long JE, Garratt AN, Fischer TM, Gassmann M, Birchmeier C et al (2004). Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 44: 251-261.
103. Flames N, Pla R, Gelman DM, Rubenstein JL, Puelles L, Marin O (2007). Delineation of multiple subpallial progenitor domains by the combinatorial expression of transcriptional codes. J Neurosci 27: 9682-9695.
104. Folsom TD, Fatemi SH (2013). The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 68: 122-135.
105. Freund TF (2003). Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci 26: 489-495.
106. Freund TF, Katona I (2007). Perisomatic inhibition. Neuron 56: 33-42.
107. Frotscher M (2010). Role for Reelin in stabilizing cortical architecture. Trends Neurosci 33: 407-414.
108. Gamo NJ, Duque A, Paspalas CD, Kata A, Fine R, Boven L et al (2013). Role of disrupted in schizophrenia 1 (DISC1) in stress-induced prefrontal cognitive dysfunction. Transl Psychiatry 3: e328.
109. Gao SF, Klomp A, Wu JL, Swaab DF, Bao AM (2013). Reduced GAD(65/67) immunoreactivity in the hypothalamic paraventricular nucleus in depression: a postmortem study. J Affect Disord 149: 422-425.
110. Garbett KA, Horvath S, Ebert PJ, Schmidt MJ, Lwin K, Mitchell A et al (2010). Novel animal models for studying complex brain disorders: BAC-driven miRNAmediated in vivo silencing of gene expression. Mol Psychiatry 15: 987-995.
111. Garbett KA, Hsiao EY, Kalman S, Patterson PH, Mirnics K (2012). Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl Psychiatry 2: e98.
112. Ge S, Goh EL, Sailor KA, Kitabatake Y, Ming GL, Song H (2006). GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature 439: 589-593.
113. Geuze E, van Berckel BN, Lammertsma AA, Boellaard R, de Kloet CS, Vermetten E et al (2008). Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol Psychiatry 13: 74-83. 73.
114. Giovanoli S, Engler H, Engler A, Richetto J, Voget M, Willi R et al (2013). Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339: 1095-1099.
115. Giusti-Rodriguez P, Sullivan PF (2013). The genomics of schizophrenia: update and implications. J Clin Invest 123: 4557-4563.
116. Glorioso C, Sabatini M, Unger T, Hashimoto T, Monteggia LM, Lewis DA et al (2006). Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol Psychiatry 11: 633-648.
117. Gorski JA, Zeiler SR, Tamowski S, Jones KR (2003). Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23: 6856-6865.
118. Gothelf D, Frisch A, Munitz H, Rockah R, Aviram A, Mozes T et al (1997). Velocardiofacial manifestations and microdeletions in schizophrenic inpatients. Am J Med Genet 72: 455-461.
119. Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: metaanalysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 61: 911-922.
120. Grayson DR, Chen Y, Costa E, Dong E, Guidotti A, Kundakovic M et al (2006). The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol Ther 111: 272-286.
121. Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A et al (2005). Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 102: 9341-9346.
122. Greig LC, Woodworth MB, Galazo MJ, Padmanabhan H, Macklis JD (2013). Molecular logic of neocortical projection neuron specification, development and diversity. Nat Rev Neurosci 14: 755-769.
123. Grozeva D, Kirov G, Ivanov D, Jones IR, Jones L, Green EK et al (2010). Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 67: 318-327.
124. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR et al (2000a). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57: 1061-1069.
125. Guidotti A, Pesold C, Costa E (2000b). New neurochemical markers for psychosis: a working hypothesis of their operation. Neurochem Res 25: 1207-1218.
126. Guo J, Anton ES (2014). Decision making during interneuron migration in the developing cerebral cortex. Trends Cell Biol pii: S0962-8924(13)00224-9. doi:10.1016/j.tcb.2013.12.001. (Epub ahead of print).
127. Haas M, Qu Z, Kim TH, Vargas E, Campbell K, Petrou S et al (2013). Perturbations in cortical development and neuronal network excitability arising from prenatal exposure to benzodiazepines in mice. Eur J Neurosci 37: 1584-1593.
128. Habl G, Schmitt A, Zink M, von Wilmsdorff M, Yeganeh-Doost P, Jatzko A et al (2012). Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients. Neuropsychobiology 66: 57-62.
129. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I et al (2000). Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12: 3239-3249.
130. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al (2001). Genomewide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98: 4746-4751.
131. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF et al (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23: 6690-6694.
132. Harrison PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Part 4): 593-624.
133. Harrison PJ, Law AJ (2006). Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 60: 132-140.
134. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol psychiatry 10: 40-68. image 45.
135. Hashimoto-Torii K, Torii M, Sarkisian MR, Bartley CM, Shen J, Radtke F et al (2008). Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. Neuron 60: 273-284.
136. Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR (2004). Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 9: 299-307.
137. Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, Volk DW et al (2008a). Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 13: 147-161.
138. Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA (2008b). Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 165: 479-489.
139. Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN et al (2005). Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 25: 372-383.
140. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z et al (2003). Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23: 6315-6326.
141. Heckers S (1997). Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr Bull 23: 403-421.
142. Heckers S, Heinsen H, Geiger B, Beckmann H (1991). Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry 48: 1002-1008.
143. Hefft S, Jonas P (2005). Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 8: 1319-1328.
144. Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM (2008). Gene- environment interplay between cannabis and psychosis. Schizophr Bull 34: 1111-1121.
145. Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA (2013). Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. Schizophr Bull (Epub ahead of print) PMID:24361861.
146. Horvath S, Janka Z, Mirnics K (2011). Analyzing schizophrenia by DNA microarrays. Biol Psychiatry 69: 157-162.
147. Horvath S, Mirnics K (2009). Breaking the gene barrier in schizophrenia. Nat Med 15: 488-490.
148. Horvath S, Mirnics K (2014a). Immune system disturbances in schizophrenia. Biol Psychiatry 75: 316-323.
149. Horvath S, Mirnics K (2014b). Schizophrenia as a disorder of molecular pathways. Biol Psychiatry pii: S0006-3223(14)00007-9. doi:10.1016/j.biopsych.2014.01.001. (Epub ahead of print) PMID:24507510.
150. Hou XJ, Ni KM, Yang JM, Li XM (2013). Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses. Neuroscience 261: 107-117.
151. Huang EJ, Reichardt LF (2001). Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736.
152. Huang HS, Akbarian S (2007). GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One 2: e809.
153. Huang ZJ, Kirkwood A, Pizzorusso T, Porciatti V, Morales B, Bear MF et al (1999). BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98: 739-755.
154. Hyde TM, Lipska BK, Ali T, Mathew SV, Law AJ, Metitiri OE et al (2011). Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia. J Neurosci 31: 11088-11095.
155. Ibi D, Nagai T, Koike H, Kitahara Y, Mizoguchi H, Niwa M et al (2010). Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behav Brain Res 206: 32-37.
156. Ibi D, Nagai T, Nakajima A, Mizoguchi H, Kawase T, Tsuboi D et al (2013). Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice. Glia 61: 679-693.
157. Ikeda K, Ikeda K, Iritani S, Ueno H, Niizato K (2004). Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28: 379-383.
158. Ikeda T, Tamura N, Matsuki N, Yamada MK (2006). Conserved role of brain-derived neurotrophic factor in Val66Met: target-selective reinforcement of GABAergic synapses. NeuroReport 17: 1847-1851.
159. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG et al (1998). A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95: 15718-15723.
160. Insel TR (2010). Rethinking schizophrenia. Nature 468: 187-193.
161. International Schizophrenia C (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455: 237-241.
162. Iritani S, Kuroki N, Niizato K, Ikeda K (2000). Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics. Progr Neuro-Psychopharmacol Biol Psychiatry 24: 241-249.
163. Jaaro-Peled H (2009). Gene models of schizophrenia: DISC1 mouse models. Prog Brain Res 179: 75-86.
164. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A (2009). Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci 32: 485-495.
165. Jakob H, Beckmann H (1986). Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65: 303-326.
166. Javitt DC (2012). Twenty-five years of glutamate in schizophrenia: are we there yet? Schizophr Bull 38: 911-913.
167. Joshi D, Fung SJ, Rothwell A, Weickert CS (2012). Higher gamma-aminobutyric acid neuron density in the white matter of orbital frontal cortex in schizophrenia. Biol Psychiatry 72: 725-733.
168. Kalkman HO, Loetscher E (2003). GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis. J Neural Transm 110: 803-812.
169. Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y et al (2005). A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7: 1167-1178.
170. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT (2007). Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 17: 165-170.
171. Kang JQ, Macdonald RL (2009). Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies. Trends Mol Med 15: 430-438.
172. Karayiorgou M, Simon TJ, Gogos JA (2010). 22q11.2 Microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci 11: 402-416.
173. Karson MA, Tang AH, Milner TA, Alger BE (2009). Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus. J Neurosci 29: 4140-4154.
174. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N et al (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21: 9506-9518.
175. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K et al (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544-4558.
176. Kim JY, Liu CY, Zhang F, Duan X, Wen Z, Song J et al (2012). Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia. Cell 148: 1051-1064.
177. Kirkpatrick B, Conley RC, Kakoyannis A, Reep RL, Roberts RC (1999). Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: an unbiased cell-counting study. Synapse 34: 95-102.
178. Kirkpatrick B, Messias NC, Conley RR, Roberts RC (2003). Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J Nerv Ment Dis 191: 563-567.
179. Klausberger T, Somogyi P (2008). Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321: 53-57.
180. Knable MB, Barci BM, Bartko JJ, Webster MJ, Torrey EF (2002). Molecular abnormalities in the major psychiatric illnesses: classification and regression tree (CRT) analysis of post-mortem prefrontal markers. Mol Psychiatry 7: 392-404.
181. Knusel B, Rabin SJ, Hefti F, Kaplan DR (1994). Regulated neurotrophin receptor responsiveness during neuronal migrationand early differentiation. J Neurosci 14(Part 2): 1542-1554.
182. Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H et al (2011). Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res 131: 165-173.
183. Kostovic I, Rakic P (1990). Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J Comp Neurol 297: 441-470.
184. Kovalenko S, Bergmann A, Schneider-Axmann T, Ovary I, Majtenyi K, Havas L et al (2003). Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis. Pharmacopsychiatry 36(Suppl 3): S158-S161.
185. Kreczmanski P, Heinsen H, Mantua V, Woltersdorf F, Masson T, Ulfig N et al (2007). Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain 130(Part 3): 678-692.
186. Kundakovic M, Chen Y, Guidotti A, Grayson DR (2009). The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol 75: 342-354.
187. Kuromitsu J, Yokoi A, Kawai T, Nagasu T, Aizawa T, Haga S et al (2001). Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Brain Res Gene Expr Patterns 1: 17-21.
188. Kutiyanawalla A, Promsote W, Terry A, Pillai A (2012). Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice. Int J Neuropsychopharmacol 15: 1073-1086.
189. Kvitsiani D, Ranade S, Hangya B, Taniguchi H, Huang JZ, Kepecs A (2013). Distinct behavioural and network correlates of two interneuron types in prefrontal cortex. Nature 498: 363-366.
190. Lambert de Rouvroit C, Goffinet AM (1998). The reeler mouse as a model of brain development. Adv Anat Embryol Cell Biol 150: 1-106.
191. Law AJ, Kleinman JE, Weinberger DR, Weickert CS (2007). Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 16: 129-141.
192. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R et al (2006). Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci USA 103: 6747-6752.
193. Lazarus MS, Krishnan K, Huang ZJ (2013). GAD67 deficiency in parvalbumin interneurons produces deficits in inhibitory transmission and network disinhibition in mouse prefrontal cortex. Cereb Cortex (Epub ahead of print) PMID:24275833.
194. Levav-Rabkin T, Melamed O, Clarke G, Farber M, Cryan JF, Dinan TG et al (2010). A sensitive period of mice inhibitory system to neonatal GABA enhancement by vigabatrin is brain region dependent. Neuropsychopharmacology 35: 1138-1154.
195. Levitt P (2005). Disruption of interneuron development. Epilepsia 46(Suppl 7): 22-28.
196. Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA (2006). Making the case for a candidate vulnerability gene in schizophrenia: convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry 60: 534-537.
197. Lewis DA, Curley AA, Glausier JR, Volk DW (2012). Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 35: 57-67.
198. Lewis DA, Hashimoto T, Volk DW (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6: 312-324.
199. Lewis DA, Levitt P (2002). Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25: 409-432.
200. Lewis DA, Lieberman JA (2000). Catching up on schizophrenia: natural history and neurobiology. Neuron 28: 325-334.
201. Lewis DA, Mirnics K (2006). Transcriptome alterations in schizophrenia: disturbing the functional architecture of the dorsolateral prefrontal cortex. Progr Brain Res 158: 141-152.
202. Li KX, Lu YM, Xu ZH, Zhang J, Zhu JM, Zhang JM et al (2012). Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat Neurosci 15: 267-273.
203. Lipina TV, Zai C, Hlousek D, Roder JC, Wong AH (2013). Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J Neurosci 33: 7654-7666.
204. Losonczy A, Biro AA, Nusser Z (2004). Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci USA 101: 1362-1367.
205. LoTurco JJ, Owens DF, Heath MJ, Davis MB, Kriegstein AR (1995). GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 15: 1287-1298.
206. Lovett-Barron M, Turi GF, Kaifosh P, Lee PH, Bolze F, Sun XH et al (2012). Regulation of neuronal input transformations by tunable dendritic inhibition. Nat Neurosci 15: 423-430.
207. Malaspina D (2001). Paternal factors and schizophrenia risk: de novo mutations and imprinting. Schizophr Bull 27: 379-393.
208. Maldonado-Aviles JG, Curley AA, Hashimoto T, Morrow AL, Ramsey AJ, O'Donnell P et al (2009). Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 166: 450-459.
209. Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ (1998). Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 55: 715-720.
210. Maloku E, Covelo IR, Hanbauer I, Guidotti A, Kadriu B, Hu Q et al (2010). Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression. Proc Natl Acad Sci USA 107: 4407-4411.
211. Manent JB, Demarque M, Jorquera I, Pellegrino C, Ben-Ari Y, Aniksztejn L et al (2005). A noncanonical release of GABA and glutamate modulates neuronal migration. J Neurosci 25: 4755-4765.
212. Manent JB, Jorquera I, Mazzucchelli I, Depaulis A, Perucca E, Ben-Ari Y et al (2007). Fetal exposure to GABA-acting antiepileptic drugs generates hippocampal and cortical dysplasias. Epilepsia 48: 684-693.
213. Manko M, Bienvenu TC, Dalezios Y, Capogna M (2012). Neurogliaform cells of amygdala: a source of slow phasic inhibition in the basolateral complex. J Physiol 590(Part 22): 5611-5627.
214. Marballi K, Quinones MP, Jimenez F, Escamilla MA, Raventos H, Soto-Bernardini MC et al (2010). In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation. J Mol Med (Berl) 88: 1133-1141.
215. Marenco S, Weinberger DR (2000). The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 12: 501-527.
216. Maric D, Liu QY, Maric I, Chaudry S, Chang YH, Smith SV et al (2001). GABA expression dominates neuronal lineage progression in the embryonic rat neocortex and facilitates neurite outgrowth via GABA(A) autoreceptor/Cl- channels. J Neurosci 21: 2343-2360.
217. Marin O (2012). Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci 13: 107-120.
218. Marin O, Rubenstein JL (2001a). A long, remarkable journey: tangential migration in the telencephalon. Nat Rev Neurosci 2: 780-790.
219. Marin O, Rubenstein JL (2003). Cell migration in the forebrain. Annu Rev Neurosci 26: 441-483.
220. Marin O, Yaron A, Bagri A, Tessier-Lavigne M, Rubenstein JL (2001b). Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions. Science 293: 872-875.
221. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C (2004). Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5: 793-807.
222. Marty S, Berninger B, Carroll P, Thoenen H (1996). GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brainderived neurotrophic factor. Neuron 16: 565-570.
223. Mata I, Perez-Iglesias R, Roiz-Santianez R, Tordesillas-Gutierrez D, Gonzalez- Mandly A, Berja A et al (2010). Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. NeuroImage 53: 1016-1022.
224. McAllister AK (2014). Major histocompatibility complex I in brain development and schizophrenia. Biol Psychiatry 75: 262-268.
225. McAllister AK, Katz LC, Lo DC (1997). Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 18: 767-778.
226. McGlashan TH, Hoffman RE (2000). Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57: 637-648.
227. Mei L, Xiong WC (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 9: 437-452.
228. Mellios N, Huang HS, Baker SP, Galdzicka M, Ginns E, Akbarian S (2009). Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 65: 1006-1014.
229. Metin C, Vallee RB, Rakic P, Bhide PG (2008). Modes and mishaps of neuronal migration in the mammalian brain. J Neurosci 28: 11746-11752.
230. Meyer G, Wahle P, Castaneyra-Perdomo A, Ferres-Torres R (1992). Morphology of neurons in the white matter of the adult human neocortex. Exp Brain Res 88: 204-212.
231. Meyer U (2014). Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75: 307-315.
232. Michel M, Schmidt MJ, Mirnics K (2012). Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol 72: 1277-1287.
233. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P (2002). Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22: 2718-2729.
234. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L et al (2008). Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 82: 696-711.
235. Mirnics K, Levitt P, Lewis DA (2006). Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry 60: 163-176.
236. Mirnics K, Lewis DA (2001a). Genes and subtypes of schizophrenia. Trends Mol Med 7: 281-283.
237. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001b). Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24: 479-486.
238. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P (2000). Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: 53-67.
239. Mirnics K, Pevsner J (2004). Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 7: 434-439.
240. Mitchell RM, Janssen MJ, Karavanova I, Vullhorst D, Furth K, Makusky A et al (2013). ErbB4 reduces synaptic GABAA currents independent of its receptor tyrosine kinase activity. Proc Natl Acad Sci USA 110: 19603-19608.
241. Mohler H (2012). The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62: 42-53.
242. Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD (2007). Neuronal subtype specification in the cerebral cortex. Nat Rev Neurosci 8: 427-437.
243. Morris HM, Hashimoto T, Lewis DA (2008). Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex 18: 1575-1587.
244. Mowry BJ, Gratten J (2013). The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants. Mol Psychiatry 18: 38-52.
245. Muir WJ, Pickard BS, Blackwood DH (2008). Disrupted-in-schizophrenia-1. Curr Psychiatry Rep 10: 140-147.
246. Murphy KC, Jones LA, Owen MJ (1999). High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56: 940-945.
247. Nadarajah B, Parnavelas JG (2002). Modes of neuronal migration in the developing cerebral cortex. Nat Rev Neurosci 3: 423-432.
248. Neddens J, Fish KN, Tricoire L, Vullhorst D, Shamir A, Chung W et al (2011). Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol Psychiatry 70: 636-645.
249. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P et al (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10: 208-212.
250. Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y et al (2013). Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 339: 335-339.
251. Noh JS, Sharma RP, Veldic M, Salvacion AA, Jia X, Chen Y et al (2005). DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc Natl Acad Sci USA 102: 1749-1754.
252. Norman RM, Malla AK (1993). Stressful life events and schizophrenia. I: a review of the research. Br J Psychiatry 162: 161-166.
253. Nullmeier S, Panther P, Dobrowolny H, Frotscher M, Zhao S, Schwegler H et al (2011). Region-specific alteration of GABAergic markers in the brain of heterozygous reeler mice. Eur J Neurosci 33: 689-698.
254. Nyffeler M, Meyer U, Yee BK, Feldon J, Knuesel I (2006). Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 143: 51-62.
255. O'Donnell P (2012). Cortical interneurons, immune factors and oxidative stress as early targets for schizophrenia. Eur J Neurosci 35: 1866-1870.
256. Ohba S, Ikeda T, Ikegaya Y, Nishiyama N, Matsuki N, Yamada MK (2005). BDNF locally potentiates GABAergic presynaptic machineries: target-selective circuit inhibition. Cereb Cortex 15: 291-298.
257. Olah S, Fule M, Komlosi G, Varga C, Baldi R, Barzo P et al (2009). Regulation of cortical microcircuits by unitary GABA-mediated volume transmission. Nature 461: 1278-1281.
258. Owens DF, Kriegstein AR (2002). Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3: 715-727.
259. Papaleo F, Lipska BK, Weinberger DR (2012). Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology 62: 1204-1220.
260. Park H, Poo MM (2013). Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 14: 7-23.
261. Pascual M, Perez-Sust P, Soriano E (2004). The GABAergic septohippocampal pathway in control and reeler mice: target specificity and termination onto Reelinexpressing interneurons. Mol Cell Neurosci 25: 679-691.
262. Patel S, Kingsley PJ, Mackie K, Marnett LJ, Winder DG (2009). Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances shortterm endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 34: 2699-2709.
263. Patterson PH (2009). Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204: 313-321.
264. Paus T, Keshavan M, Giedd JN (2008). Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 9: 947-957.
265. Pennington K, Dicker P, Hudson L, Cotter DR (2008). Evidence for reduced neuronal somal size within the insular cortex in schizophrenia, but not in affective disorders. Schizophr Res 106: 164-171.
266. Pesold C, Liu WS, Guidotti A, Costa E, Caruncho HJ (1999). Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression. Proc Natl Acad Sci USA 96: 3217-3222.
267. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE et al (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24: 10099-10102.
268. Pi HJ, Hangya B, Kvitsiani D, Sanders JI, Huang ZJ, Kepecs A (2013). Cortical interneurons that specialize in disinhibitory control. Nature 503: 521-524.
269. Pillai A, Mahadik SP (2008). Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Schizophr Res 100: 325-333.
270. Piontkewitz Y, Bernstein HG, Dobrowolny H, Bogerts B, Weiner I, Keilhoff G (2012). Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav Immun 26: 353-363.
271. Pla R, Borrell V, Flames N, Marin O (2006). Layer acquisition by cortical GABAergic interneurons is independent of Reelin signaling. J Neurosci 26: 6924-6934.
272. Polleux F, Whitford KL, Dijkhuizen PA, Vitalis T, Ghosh A (2002). Control of cortical interneuron migration by neurotrophins and PI3-kinase signaling. Development 129: 3147-3160.
273. Price CJ, Cauli B, Kovacs ER, Kulik A, Lambolez B, Shigemoto R et al (2005). Neurogliaform neurons form a novel inhibitory network in the hippocampal CA1 area. J Neurosci 25: 6775-6786.
274. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
275. Rajkowska G, Selemon LD, Goldman-Rakic PS (1998). Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 55: 215-224.
276. Rapoport JL, Giedd JN, Gogtay N (2012). Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 17: 1228-1238.
277. Rees E, Kirov G, Sanders A, Walters JT, Chambert KD, Shi J et al (2014). Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry 19: 37-40.
278. Reich CG, Mihalik GR, Iskander AN, Seckler JC, Weiss MS (2013). Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. Neuroscience 253: 444-454.
279. Richetto J, Calabrese F, Riva MA, Meyer U (2013). Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophr Bull 40: 351-361.
280. Rico B, Marin O (2011). Neuregulin signaling, cortical circuitry development and schizophrenia. Curr Opin Genet Dev 21: 262-270.
281. Ringstedt T, Linnarsson S, Wagner J, Lendahl U, Kokaia Z, Arenas E et al (1998). BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex. Neuron 21: 305-315.
282. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S et al (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45: 1150-1159.
283. Rodriguez MA, Caruncho HJ, Costa E, Pesold C, Liu WS, Guidotti A (2002). In Patas monkey, glutamic acid decarboxylase-67 and reelin mRNA coexpression varies in a manner dependent on layers and cortical areas. J Comp Neurol 451: 279-288.
284. Roth TL, Lubin FD, Funk AJ, Sweatt JD (2009). Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 65: 760-769.
285. Roussos P, Katsel P, Davis KL, Siever LJ, Haroutunian V (2012). A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry 69: 1205-1213.
286. Ruzicka WB, Zhubi A, Veldic M, Grayson DR, Costa E, Guidotti A (2007). Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol Psychiatry 12: 385-397.
287. Schmid RS, McGrath B, Berechid BE, Boyles B, Marchionni M, Sestan N et al (2003). Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex. Proc Natl Acad Sci USA 100: 4251-4256.
288. Schmidt-Kastner R, van Os J, Esquivel G, Steinbusch HW, Rutten BP (2012). An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry 17: 1194-1205.
289. Schmidt MJ, Horvath S, Ebert P, Norris JL, Seeley EH, Brown J et al (2013). Modulation of behavioral networks by selective interneuronal inactivation. Mol Psychiatry 19: 529.
290. Schmidt MJ, Mirnics K (2012). Modeling interneuron dysfunction in schizophrenia. Dev Neurosci 34: 152-158.
291. Selemon LD, Goldman-Rakic PS (1999). The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45: 17-25.
292. Selemon LD, Mrzljak J, Kleinman JE, Herman MM, Goldman-Rakic PS (2003). Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9. Arch Gen Psychiatry 60: 69-77.
293. Selemon LD, Rajkowska G, Goldman-Rakic PS (1995). Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52: 805-818. discussion 819-820.
294. Selemon LD, Rajkowska G, Goldman-Rakic PS (1998). Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a threedimensional, stereologic counting method. J Comp Neurol 392: 402-412.
295. Shamir A, Kwon OB, Karavanova I, Vullhorst D, Leiva-Salcedo E, Janssen MJ et al (2012). The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J Neurosci 32: 2988-2997.
296. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I et al (2009). Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
297. Siegel BI, Sengupta EJ, Edelson JR, Lewis DA, Volk DW (2013). Elevated viral restriction factor levels in cortical blood vessels in schizophrenia. Biol Psychiatry pii: S0006-3223(13)00860-3. doi:10.1016/j.biopsych.2013.09.019. (Epub ahead of print) PMID:24209773.
298. Smiley JF, Konnova K, Bleiwas C (2012). Cortical thickness, neuron density and size in the inferior parietal lobe in schizophrenia. Schizophr Res 136: 43-50.
299. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH (2007). Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27: 10695-10702.
300. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G et al (1990). Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336: 13-16.
301. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al (2009). Common variants conferring risk of schizophrenia. Nature 460: 744-747.
302. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S et al (2008). Large recurrent microdeletions associated with schizophrenia. Nature 455: 232-236.
303. Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K (2004). Neuregulin 1 and schizophrenia. Ann Med 36: 62-71.
304. Sullivan PF, Kendler KS, Neale MC (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60: 1187-1192.
305. Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S et al (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10: 631-636.
306. Takayama C (1994). Altered distribution of inhibitory synaptic terminals in reeler cerebellum with special reference to malposition of GABAergic neurons. Neurosci Res 20: 239-250.
307. Tan H, Lauzon NM, Bishop SF, Bechard MA, Laviolette SR (2010). Integrated cannabinoid CB1 receptor transmission within the amygdala-prefrontal cortical pathway modulates neuronal plasticity and emotional memory encoding. Cereb Cortex 20: 1486-1496.
308. Tandon R, Keshavan MS, Nasrallah HA (2008). Schizophrenia, 'just the facts' what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 102: 1-18.
309. Tao R, Li C, Newburn EN, Ye T, Lipska BK, Herman MM et al (2012). Transcriptspecific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders. J Neurosci 32: 5216-5222.
310. Thompson BL, Levitt P, Stanwood GD (2009). Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci 10: 303-312.
311. Thompson Ray M, Weickert CS, Wyatt E, Webster MJ (2011). Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36: 195-203.
312. Tissir F, Goffinet AM (2003). Reelin and brain development. Nat Rev Neurosci 4: 496-505.
313. Tochigi M, Iwamoto K, Bundo M, Komori A, Sasaki T, Kato N et al (2008). Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry 63: 530-533.
314. Tost H, Alam T, Geramita M, Rebsch C, Kolachana B, Dickinson D et al (2013). Effects of the BDNF Val66Met polymorphism on white matter microstructure in healthy adults. Neuropsychopharmacology 38: 525-532.
315. Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, Someya T et al (2002). Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 110: 249-257.
316. Trost S, Platz B, Usher J, Scherk H, Wobrock T, Ekawardhani S et al (2013). DISC1 (disrupted-in-schizophrenia 1) is associated with cortical grey matter volumes in the human brain: a voxel-based morphometry (VBM) study. J Psychiatr Res 47: 188-196.
317. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9: 519-525.
318. Tsuang M (2000). Schizophrenia: genes and environment. Biol Psychiatry 47: 210-220.
319. Uhlhaas PJ, Singer W (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11: 100-113.
320. van Os J, Kenis G, Rutten BP (2010). The environment and schizophrenia. Nature 468: 203-212.
321. Varga V, Losonczy A, Zemelman BV, Borhegyi Z, Nyiri G, Domonkos A et al (2009). Fast synaptic subcortical control of hippocampal circuits. Science 326: 449-453.
322. Vassos E, Pedersen CB, Murray RM, Collier DA, Lewis CM (2012). Meta-analysis of the association of urbanicity with schizophrenia. Schizophr Bull 38: 1118-1123.
323. Veldic M, Caruncho HJ, Liu WS, Davis J, Satta R, Grayson DR et al (2004). DNAmethyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci USA 101: 348-353.
324. Veldic M, Kadriu B, Maloku E, Agis-Balboa RC, Guidotti A, Davis JM et al (2007). Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res 91: 51-61.
325. Vicario-Abejon C, Owens D, McKay R, Segal M (2002). Role of neurotrophins in central synapse formation and stabilization. Nat Rev Neurosci 3: 965-974.
326. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA (2000). Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57: 237-245.
327. Volk DW, Lewis DA (2002a). Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 77: 501-505.
328. Volk DW, Matsubara T, Li S, Sengupta EJ, Georgiev D, Minabe Y et al (2012). Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry 169: 1082-1091.
329. Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA (2002b). Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 12: 1063-1070.
330. Walker E, Mittal V, Tessner K (2008). Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 4: 189-216.
331. Wang AY, Lohmann KM, Yang CK, Zimmerman EI, Pantazopoulos H, Herring N et al (2011). Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol 122: 615-626.
332. Wang DD, Kriegstein AR (2008). GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. J Neurosci 28: 5547-5558.
333. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE (2003). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8: 592-610.
334. Weinberger DR (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660-669.
335. Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ et al (2010). Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci USA 107: 1211-1216.
336. Wonders CP, Anderson SA (2006). The origin and specification of cortical interneurons. Nat Rev Neurosci 7: 687-696.
337. Wong J, Hyde TM, Cassano HL, Deep-Soboslay A, Kleinman JE, Weickert CS (2010). Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience 169: 1071-1084.
338. Woo NH, Lu B (2006). Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 12: 43-56.
339. Wood JD, Bonath F, Kumar S, Ross CA, Cunliffe VT (2009). Disrupted-inschizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. Hum Mol Genet 18: 391-404.
340. Woodruff AR, Anderson SA, Yuste R (2010). The enigmatic function of chandelier cells. Front Neurosci 4: 201.
341. Wu X, Fu Y, Knott G, Lu J, Di Cristo G, Huang ZJ (2012). GABA signaling promotes synapse elimination and axon pruning in developing cortical inhibitory interneurons. J Neurosci 32: 331-343.
342. Yamada MK, Nakanishi K, Ohba S, Nakamura T, Ikegaya Y, Nishiyama N et al (2002). Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J Neurosci 22: 7580-7585.
343. Yang Y, Fung SJ, Rothwell A, Tianmei S, Weickert CS (2011). Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 69: 63-70.
344. Young KA, Manaye KF, Liang C, Hicks PB, German DC (2000). Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry 47: 944-953.